About Nira Life Sciences
Nira Life Sciences is a Healthcare company based in Rajkot (India) founded in 2012. It manufactures high-quality pharmaceutical APIs and intermediates for global markets. It operates on a B2B model. The company has 85 employees. Its Indian entity Nira Life Sciences Private Limited reported revenue of ₹37.10 Cr. Nira Life Sciences offers products and services including Mefenamic Acid, Tolfenamic Acid, Benfotiamine, and Nitazoxanide. Its focus areas include Pharmaceuticals, API Manufacturing, Active Ingredients and Chemical Intermediates. Similar companies include Laurus Labs, Symbiotec and SeQuent; 2 of its 3 listed similar companies have raised funding.
Company details
Nira Life Sciences Pvt. Ltd. is a leading pharmaceutical company based in Gujarat, India, specializing in the production of active pharmaceutical ingredients like Mefenamic Acid. They operate advanced manufacturing facilities with WHO-GMP and ISO standards, focusing on research, development, and quality assurance. The company exports products worldwide, emphasizing innovation and compliance to meet global demands while serving various pharmaceutical clients through B2B channels.
- Headquarters Rajkot, India
- Employees 85
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website niralifesciences.com
- Social LinkedIn X
- Legal Name Nira Life Sciences Private Limited
- Date of Incorporation 03 Feb, 2012
- Jurisdiction Rajkot, Gujarat, India
- Annual Revenue₹37.10 Cr
FY 2024 · -18% YoY
- Net Profit₹3.10 Cr
FY 2024 · 8% margin
- EBITDA₹5.86 Cr
FY 2024 · 16% margin
- Employee Count85
Associated legal entities of Nira Life Sciences
Nira Life Sciences operates through Nira Life Sciences Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2024) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Nira Life Sciences Private Limited CIN U24230GJ2012PTC068865 | Active | 03 Feb 2012 | Rajkot, Gujarat | ₹37.1 Cr | 85 | 6 | View details |
Products & Services of Nira Life Sciences
Nira Life Sciences offers a comprehensive portfolio of products and services, including Mefenamic Acid, Tolfenamic Acid, Benfotiamine, and Nitazoxanide.
Active ingredient used for pain relief in medications.
Compound for treating inflammation and pain conditions.
Vitamin B1 derivative for nerve health support.
Antiparasitic drug for treating infections.
Board of directors of Nira Life Sciences Private Limited (Nira Life Sciences)
Nira Life Sciences Private Limited is the primary company behind Nira Life Sciences. The board of Nira Life Sciences Private Limited currently have 6 directors; the longest-serving is Suresh Devjibhai Sorathiya, appointed in 2012.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Suresh Devjibhai Sorathiya DIN 03507209 | Director | 03 Feb 2012 | 14 yrs 8 mo | Nira Life Sciences Private Limited |
| Mahendra Govindbhai Ranparia DIN 05185602 | Director | 03 Feb 2012 | 14 yrs 8 mo | Nira Life Sciences Private Limited |
| Ranjanben Sureshbhai Sorathiya DIN 05185606 | Director | 03 Feb 2012 | 14 yrs 8 mo | Nira Life Sciences Private Limited |
| Ghanashyam Govindbhai Harsoda DIN 05186829 | Director | 03 Feb 2012 | 14 yrs 8 mo | Nira Life Sciences Private Limited |
| Kishorbhai Tulsibhai Sorathiya DIN 05176452 | Director | 03 Feb 2012 | 14 yrs 8 mo | Nira Life Sciences Private Limited |
| Vishal Kesavlal Shankhavara DIN 05176454 | Director | 03 Feb 2012 | 14 yrs 8 mo | Nira Life Sciences Private Limited |
Financials of Nira Life Sciences
Figures of Nira Life Sciences Private Limited, the primary company behind Nira Life Sciences, for FY 2024. Revenue was ₹37.10 Cr (-18% year on year). Net profit was ₹3.10 Cr (8% margin). EBITDA was ₹5.86 Cr (16% margin). Revenue has grown at a compounded annual rate of +4% over three years and +8% over five years.
- ₹37.10 CrRevenue · FY 2024 · -18% YoY
- ₹3.10 CrNet profit · 8% margin
- ₹5.86 CrEBITDA · 16% margin
- ₹1.30 CrPaid-up capital
- 85Employees (provident fund records)
- +4%Revenue CAGR, 3 years
- +8%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Nira Life Sciences Private Limited are on its company page.
Detailed financial statements for Nira Life Sciences
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Similar companies to Nira Life Sciences
Nira Life Sciences has 3 listed similar companies in our database, 2 of them funded. They include Laurus Labs, Symbiotec and SeQuent.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| lauruslabs.com | 2005 | Hyderabad, India | $229.73M | 6,035 | Pharmaceutical and biotechnology company | |
| symbiotec.in | 2002 | Indore, India | $61.01M | 1,822 | Non-sterile steroid hormone-based APIs and intermediates are manufactured. | |
| sequent.in | 2002 | Bengaluru, India | APIs are developed and manufactured for therapeutic areas. |
Detailed similar companies of Nira Life Sciences
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Nira Life Sciences
Nira Life Sciences was founded in 2012.
Nira Life Sciences is headquartered in Rajkot, India. It is registered at Rajkot, Gujarat, India.
Nira Life Sciences has 85 employees.
The primary company behind Nira Life Sciences, Nira Life Sciences Private Limited, reported revenue of ₹37.10 Cr for FY 2024, down 18% year on year.
Nira Life Sciences Pvt. Ltd. is a leading pharmaceutical company based in Gujarat, India, specializing in the production of active pharmaceutical ingredients like Mefenamic Acid. They operate advanced manufacturing facilities with WHO-GMP and ISO standards, focusing on research, development, and quality assurance. The company exports products worldwide, emphasizing innovation and compliance to meet global demands while serving various pharmaceutical clients through B2B channels.
Nira Life Sciences's top competitors include Laurus Labs, Symbiotec and SeQuent.
Nira Life Sciences offers Mefenamic Acid, Tolfenamic Acid, Benfotiamine, and Nitazoxanide.
Nira Life Sciences operates through Nira Life Sciences Private Limited.
The legal entities of Nira Life Sciences currently have 6 directors, including Suresh Devjibhai Sorathiya, Mahendra Govindbhai Ranparia, Ranjanben Sureshbhai Sorathiya and others.